Welcome, Guest
Register
Sign In
Member Center
Sign Out
Register
Sign In
Go
Symbol Lookup
Loading...
Go
HOME
NEWS
U.S.
Asia
Europe
Economy
Energy
Inside Wealth
Politics
Technology
Blogs
Slideshows
Special Reports
Corrections
MARKETS
Pre-Markets
US
Europe
Asia
Stocks
Commodities
Currencies
Bonds
Funds
ETFs
EARNINGS
Calendar
Surprises
Highlights
INVESTING
Stock Blog
Personal Finance
CNBC Explains
Portfolio
Watchlist
Stock Screener
Fund Screener
Small Business
Franchising
Financing
Management
Video
VIDEO
Latest Video
Top Video
U.S. Video
Europe Video
Asia Video
CEO Interviews
Analyst Interviews
CNBC TV
CNBC U.S.
CNBC Asia-Pacific
CNBC Europe
CNBC World
CNBC Pro
Streaming Stock Quotes Are
Regeneron Pharmaceuticals Inc
(REGN :
)
Real Time Stock Quote | Source:
---
Last Trade
---
*
Change
---
Volume
---
Trade Time
Symbol :
Go
[Find Symbol]
QUOTE
CHART
NEWS
PROFILE
EARNINGS
PEERS
FINANCIALS
OWNERSHIP
Earnings History
Consensus Recommendations
Peer Earnings
REGN FEATURED NEWS & ANALYSIS
LATEST ABOUT THIS TOPIC ON CNBC.COM
More
Regeneron moves higher on asthma drug study data
20 hrs ago - The Associated Press
UPDATE 1-Regeneron, Sanofi asthma drug seen as potential game changer
21 May 2013 - Reuters
Regeneron, Sanofi asthma drug seen as potential game changer
21 May 2013 - Reuters
Cramer's '4 Horsemen of the Apocalypse' for Shorts
15 May 2013
Jim Cramer's 5 Investing Sweet Spots
14 May 2013 - CNBC.com
Cramer's Six in 60: Monster Beverage, Clorox & More
14 May 2013
REUTERS SUMMIT-Biotech firms evolve from targets to acquirers
07 May 2013 - Reuters
FEATURE-Fast climbing biotech Regeneron still has room to grow
07 May 2013 - AFX
FEATURE-Fast climbing biotech Regeneron still has room to grow
07 May 2013 - Reuters
RESEARCH ALERT-Regeneron Pharmaceuticals : RBC raises price target
06 May 2013 - AFX
MORE FROM CNBC
More
Cramer's '4 Horsemen of the Apocalypse' for Shorts
15 May 2013
Jim Cramer's 5 Investing Sweet Spots
14 May 2013 - CNBC.com
Cramer's Six in 60: Monster Beverage, Clorox & More
14 May 2013
No Huddle Offense: What's Working In Pharma
03 May 2013
Wall Street Awaits April Jobs Report
03 May 2013 - CNBC.com
Jim Cramer: Common Drug Stock Mistake
01 May 2013 - CNBC.com
Cramer's Thoughts on Wednesday's Decline
01 May 2013
Tough Day for Stocks
01 May 2013
Midday Movers: H, AMT, ICE & More
01 May 2013 - CNBC.com
Cramer's Six in 60: Humana, 'Best of Breed'
01 May 2013
MORE FROM OUR PARTNERS
More
Cramer's Mad Money - The Miraculous Six Flags (5/22/13)
4 hrs ago - Seeking Alpha
Regeneron Shareholders Watching Optina Trial Closely
19 hrs ago - Seeking Alpha
LATEST TRANSCRIPTS
More
Regeneron Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conf...
20 May 2013 - Seeking Alpha
Regeneron Pharmaceuticals Management Discusses Q1 2013 Results - Earni...
03 May 2013 - Seeking Alpha
PRESS RELEASES
More
Cellectis: Compact TALENTM: the next generation of TAL effector nuclea...
21 May 2013 - Business Wire
Sanofi and Regeneron Announce Publication of Positive Phase 2a Results...
21 May 2013 - PR Newswire
The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron P...
16 May 2013 - PR Newswire
ELNs, Data Analytics, Knowledge Management: Trends, Challenges & Oppor...
15 May 2013 - PR Newswire
Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials...
15 May 2013 - PR Newswire
Regeneron Announces Upcoming 2013 Investor Conference Presentations
08 May 2013 - PR Newswire
Regeneron Acquires Full Rights to Two Novel Ophthalmology Development ...
03 May 2013 - PR Newswire
Regeneron Reports First Quarter 2013 Financial and Operating Results
03 May 2013 - PR Newswire
BioMed Realty Trust Reports First Quarter 2013 Financial Results
01 May 2013 - PR Newswire
BioNJ To Host 2ND Annual Life Sciences Industry HR Conference on May 2...
30 Apr 2013 - Business Wire
Markets
Economy
Companies
Top News & ANALYSIS
Seeking Shelter From the Storm, in Big Data
Not One, But Two Perfect Storms Could Be Brewing
Deal Nears to Buy Lender Processing: Reports
HP's Whitman: Revenue Growth Possible in 2014
Does Asia Slump Signal US Bump or Correction?
Beer? Use These Ballpark Apps, Never Leave Your Seat
Assessing Just How Much Bond Investors Lost
Britain Slaps Fine on JPMorgan's Wealth Unit
Even at JPMorgan, Jamie Dimon's Win Is Mysterious
Global Markets Reel After Nikkei's 7.3% Slide
SPECIAL OFFER
Download Free Annual Report.